中国药房2015，Vol.26Issue(16)：2165-2167,3.DOI:10.6039/j.issn.1001-0408.2015.16.02
中西药联用风险因素评估与处方审核、干预的探讨
Exploration of the Risk Assessment of the Combination of Traditional Chinese Medicine and Chemical Medicine and Prescription Review and Intervention
张华峰 1宋青 1黄进 1秦倪 1韩蒙蒙 1马超群 1宋蒙妞 1孟瑶1
作者信息
- 1. 解放军空军总医院药学部,北京100142
- 折叠
摘要
关键词
中药/中成药/中西药联用/风险管理/不良反应/处方审核Key words
Traditional Chinese medicine/Chinese patent medicine/Combination of Traditional Chinese traditional and chemical medicine/Risk management/Adverse reaction/Prescription audit分类
医药卫生引用本文复制引用
张华峰,宋青,黄进,秦倪,韩蒙蒙,马超群,宋蒙妞,孟瑶..中西药联用风险因素评估与处方审核、干预的探讨[J].中国药房,2015,26(16):2165-2167,3.
